Cost Analysis of Voriconazole Versus Liposomal Amphotericin B and Caspofungin for Primary Therapy of Invasive Aspergillosis Among High-Risk Hematologic Cancer Patients in Lebanon

Value in Health - United Kingdom
doi 10.1016/j.jval.2016.09.1366
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy